Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myotubularin-related protein 12 (MTMR12) is an adaptor subunit in complexes with active phosphatidylinositol 3-phosphate (PtdIns(3)P) 3-phosphatases. It belongs to the myotubularin-related protein family and regulates the stability of MTM1 (myotubularin) protein, which is important for the maintenance of skeletal muscle but not for muscle development itself[1][8]. MTMR12 lacks intrinsic phosphatase activity but interacts with catalytically active myotubularins to modulate phosphatidylinositide signaling[1][8]. Mutations or deficiencies in MTMR12 have been associated with centronuclear myopathies, suggesting a disease role in muscle function and maintenance[1]. MTMR12 is not known to be a direct therapeutic target (such as a receptor, enzyme, transporter, or ion channel), nor are there drugs or specific mechanisms of drug action described for this protein. It primarily serves regulatory and scaffolding functions within protein complexes related to phosphatase activity and membrane signaling[1][2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myotubularin-related protein 12 (MTMR12).